Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...

BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment Glutamine silences BATF2 and leads to a weakened immune response ...

Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...

The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...